Integrated HIV Surveillance and Prevention Programs for Health Departments

Funding Opportunity ID: 291220
Opportunity Number: CDC-RFA-PS18-1802
Opportunity Title: Integrated HIV Surveillance and Prevention Programs for Health Departments
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.940
Eligible Applicants: State governments
County governments
City or township governments
Additional Information on Eligibility: State, local, and/or territorial health departments currently funded under funding opportunity announcements PS12-1201: Comprehensive Human Immunodeficiency Virus (HIV) Prevention Programs for Health Departments and PS13-1302: National HIV Surveillance System (NHSS).
Agency Code: HHS-CDC-NCHHSTP
Agency Name: Department of Health and Human Services
Centers for Disease Control – NCHHSTP
Posted Date: Jun 27, 2017
Close Date: Sep 13, 2017 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Last Updated Date: Jun 27, 2017
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding: $399,292,872
Expected Number of Awards: 61
Description: The purpose of this funding opportunity announcement (FOA) is to implement a comprehensive HIV surveillance and prevention program to prevent new HIV infections and achieve viral suppression among persons living with HIV. In particular, the FOA promotes and supports improving health outcomes for persons living with HIV through achieving and sustaining viral suppression, and reducing health-related disparities by using quality, timely, and complete surveillance and program data to guide HIV prevention efforts. These goals are in accordance with the national prevention goals, HIV Care Continuum, and CDC’s High-Impact HIV Prevention (HIP) approach. The integration of these programs allows each jurisdiction to operate in unison and maximize the impact of federal HIV prevention funding. An integrated FOA strengthens implementation of HIP by further allowing health departments to align resources to better match the geographic burden of HIV infections within their jurisdictions and improve data collection and use for public health action. The FOA priorities are to increase individual knowledge of HIV status, prevent new infections among HIV-negative persons, reduce transmission from persons living with HIV, and strengthen interventional surveillance to enhance response capacity and intensive data-to-care activities to support sustained viral suppression. Priority activities include (but are not limited to) HIV testing; linkage to, re-engagement in, and retention in care and support achieving viral suppression; pre-exposure prophylaxis (PrEP) related activities; community-level HIV prevention activities; HIV transmission cluster investigations and outbreak response efforts.
Version: Synopsis 1

Powered by WPeMatico

Data to Care Rx: Using Real-time Prescription Claims Data to Support the HIV Care Continuum

Funding Opportunity ID: 293025
Opportunity Number: CDC-RFA-PS17-1709
Opportunity Title: Data to Care Rx: Using Real-time Prescription Claims Data to Support the HIV Care Continuum
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.941
Eligible Applicants: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility: Domestic Institutions or organizations are eligible to apply. Foreign institutions are not eligible to apply. An individual is not eligible to apply for this cooperative agreement. Applicants must propose applications that are specific to one or more of the “Focus Areas of Programmatic Interest” (HIV/AIDS, Viral Hepatitis, STD or TB prevention). Applicants who do not comply with this requirement will be determined non-responsive and will not be reviewed.
Agency Code: HHS-CDC-NCHHSTP
Agency Name: Department of Health and Human Services
Centers for Disease Control – NCHHSTP
Posted Date: Apr 06, 2017
Close Date: Jun 05, 2017 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Last Updated Date: Apr 06, 2017
Award Ceiling: $875,000
Award Floor: $0
Estimated Total Program Funding: $2,000,000
Expected Number of Awards: 1
Description: There are approximately 1.2 million people living with HIV in the United States among whom only 40% are engaged in HIV medical care and 30% have reached viral suppression. The substantial proportion of persons who are not engaged in care has important individual and public health implications because over 90% of new HIV infections are transmitted from persons with HIV who are not fully retained in medical care. Re-engaging out-of-care persons with HIV back into care, confers important individual-level health benefits and population-level prevention benefits. Use of HIV surveillance data to identify out-of-care persons, is one strategy for identifying and re-engaging out-of-care persons in care. Using surveillance data (i.e., CD4 and HIV viral load test results reported to the health department) to identify out-of-care persons and to re-engage these persons in care is called Data to Care or D2C. In the current D2C model, there is a delay in the identification of out-of-care persons due to the time interval between recommended monitoring tests (i.e., every 3-6 months) and the subsequent reporting of these tests to surveillance. Thus, the current D2C model identifies a failure to retain in care rather than identify persons at risk for dropping out of care and the model cannot intervene in the time between a gap in care and identification of being out of care. More real-time data is required to identify persons at risk of dropping out of care and to intervene prior to a gap in care or loss to care. Pharmacy prescription refill (claims) data are a source to identify HIV-infected persons, who have stopped filling antiretroviral (ARV) medications, and who are at risk for becoming out of care. Patients may elect to fill prescriptions at one of potentially many pharmacies that accept their insurance plan. Within one pharmacy network, prescriptions can be tracked across partnered pharmacies (e.g. chain drug stores). However, if a patient switches pharmacies (to another chain or independent pharmacy) the prior refill history remains with the first pharmacy. Pharmacy claims are adjudicated for an insurance company by a third-party claims processor or a pharmacy-benefit management (PBM) company. All pharmacy claims that are billed to an insurance company, for an individual patient, can be tracked through the PBM, regardless of where a patient filled the prescription. PBMs manage pharmacy benefits for ~85% of all people with prescription benefits. Because most ARVs are prescribed as a 30-day supply of medication, data from PBMs, can be used to identify persons who are not filling their medications on a monthly basis. Tracking ARV refill data can, therefore, be a more real-time indicator of poor adherence and can act as a harbinger of potential poor retention in care. Given that ~30% of persons on ARV are non-adherent, using real time pharmacy data to identify persons who fail to fill ARV prescriptions and to intervene could have a significant impact on adherence and potentially on retention in care. The purpose of the cooperative-agreement is to develop and implement a model using real-time pharmacy data to identify persons who fail to pick up prescribed ARVs, and who are at risk for poor retention in care, and to use this information for targeted adherence and retention interventions and to re-engage persons in care. The grantee, along with the Project Team, will develop and implement a 1st line intervention for persons who fail to pick up prescribed ARVs within 30 days, a 2nd line adherence /retention intervention to be conducted at the prescribing clinic or filling pharmacy for persons who fail to pick up prescribed ARVs within 60 days and a 3rd line intervention for the health department to locate persons who fail to pick up prescribed ARVS within 90 days and to re-link these individuals to the clinic or to the pharmacy. The expected outcomes of the model program are increased retention in HIV care, re-linkage to care, adherence to ARV therapy and viral load suppression. Specific activities, of the cooperative agreement, are broadly categorized into three areas: (1) develop a model to use pharmacy claims data to identify persons who fail to pick up prescribed ARVs and to target these individuals for progressive adherence interventions (2) implement the model (3) evaluate project outcomes and disseminate results.
Version: Synopsis 1

Powered by WPeMatico